tiprankstipranks
RAPT Therapeutics (RAPT)
NASDAQ:RAPT
US Market

RAPT Therapeutics (RAPT) Income Statement

Compare
363 Followers

RAPT Therapeutics Income Statement

Last quarter (Q4 2024), RAPT Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, RAPT Therapeutics's net income was $-53.25M. See RAPT Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 1.53M$ 3.81M$ 5.04M
Gross Profit
$ 0.00$ -3.55M$ -1.28M$ 2.82M$ 5.04M
Operating Expenses
$ 136.10M$ 127.06M$ 87.32M$ 73.02M$ 58.26M
Depreciation and Amortization
$ 0.00$ 1.22M$ 2.81M$ 996.00K$ 1.12M
EBITDA
$ -136.10M$ -125.85M$ -84.75M$ -68.21M$ -52.09M
Operating Income
$ -136.10M$ -127.06M$ -85.80M$ -69.21M$ -53.21M
Other Income/Expenses
$ 6.24M$ 10.26M$ 1.96M$ 5.00K$ 1.31M
Pretax Income
$ -129.87M$ -116.80M$ -83.84M$ -69.20M$ -51.90M
Net Income
$ -129.87M$ -116.80M$ -81.88M$ -68.21M$ -52.89M
Per Share Metrics
Basic EPS
$ -3.19$ -3.05$ -2.52$ -2.49$ -2.19
Diluted EPS
$ -3.19$ -3.05$ -2.52$ -2.49$ -2.19
Weighted Average Shares Outstanding
40.76M 38.34M 32.54M 27.39M 24.13M
Weighted Average Shares Outstanding (Diluted)
40.76M 38.34M 32.54M 27.39M 24.13M
Currency in USD

RAPT Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis